Bacillus subtilis SC-8 is a Gram-positive bacterium displaying narrow antagonistic activity for the Bacillus cereus group. B. subtilis SC-8 was isolated from Korean traditional fermented-soybean food. Here we report the draft genome sequence of B. subtilis SC-8, including biosynthetic genes for antibiotics that may have beneficial effects for control of food-borne pathogens.
T
he genus Bacillus produces broad-spectrum antibiotics with a variety of structures, such as bacteriocin-like compounds and lipopeptides (8) . In particular, the biochemical and genetic properties of B. subtilis have been well studied (7) . Antibiotics produced by B. subtilis have low toxicity and high biodegradability, and B. subtilis has been granted "generally recognized as safe" (GRAS) status (1) . Due to these beneficial properties, B. subtilis has been widely used for the control of food-borne pathogens (6) and therefore has importance in the fermented food industry.
B. subtilis SC-8 was isolated from Korean traditional fermented-soybean food and was found to display narrow antimicrobial activity against B. cereus group species, such as B. cereus, B. anthracis, B. mycoides, B. pseudomycoides, B. thuringiensis, and B. weihenstephanensis (4, 5) .
The genome sequence of B. subtilis SC-8 was obtained by using a combination of an Illumina GA IIx instrument (San Diego, CA) with 100-bp paired-end sequencing (29,613,094 reads; total, 2,394,595,930 bases; coverage, 578.57ϫ) and a 454 GS FLX Titanium instrument (Roche Diagnostics, Banford, CT) with 8-kbp paired-end sequencing (181,914 reads; total, 37,497,691 bases; coverage, 9.06ϫ). All generated reads were assembled into 17 contigs using the software programs GS Assembler 2.3 (Roche Diagnostics, Branford, CT) and CLC Genomics Workbench 4.5 (CLC Bio, Denmark).
The draft genome of B. subtilis SC-8 is composed of 4,138,818 bp with a 43.46% GϩC ratio. B. subtilis SC-8 includes 4,244 protein-coding genes, 83 tRNA-encoding genes, and 30 rRNA operons in its genome.
The B. subtilis SC-8 genome also includes several genes related to antimicrobial products and antibiotic biosynthetase, similar to the genomes of B. subtilis 168 (3) and B. subtilis BSn5 (2). Of these, genes related to lipopeptide, such as surfactin and plipastatin, and polyketide synthase were found in SC-8 chromosomes. In particular, the surfactin synthetase gene cluster was composed of 5 genes (BSSC8_39740 to BSSC8_39780) in the SC-8 chromosome. Meanwhile, the B. subtilis 168 and B. subtilis BSn5 genomes include a 4-gene cluster encoding surfactin synthetase. The gene encoding subtilosin A (BSSC_04620), known to be a bacteriocin-like substance, was found and was composed of 44 amino acids (aa), unlike the subtilosin A gene of B. subtilis 168 (43 aa). In contrast, the SC-8 genome lacks the sublancin gene found in B. subtilis strain 168. Potential genes related to antibiotics that were not present in B. subtilis 168 and B. subtilis BSn5 were also found in the B. subtilis SC-8 chromosome (BSSC8_21740 to BSSC8_21920). These genes may encode the novel antimicrobial peptides displaying narrow activity against the B. cereus group, as previously described (4, 5) . Therefore, B. subtilis strain SC-8 is a possible candidate for use as an antagonistic bacterium against foodborne pathogens, to prevent food poisoning, and as an alternative fermenting bacterium in the fermented-soybean food industry because of these features of the SC-8 genome.
Nucleotide sequence accession number. The draft genome sequence of Bacillus subtilis SC-8 was deposited in GenBank under accession number AGFW00000000.
